## Figures

## Abstract

### Background

Obesity is a global public health challenge. In the US, for instance, obesity prevalence remains high at more than one-third of the adult population, while over two-thirds are obese or overweight. Obesity is associated with various health problems, such as diabetes, cardiovascular diseases (CVDs), depression, some forms of cancer, sleep apnea, osteoarthritis, among others. The body mass index (BMI) is one of the best known measures of obesity. The BMI, however, has serious limitations, for instance, its inability to capture the distribution of lean mass and adipose tissue, which is a better predictor of diabetes and CVDs, and its curved (“U-shaped”) relationship with mortality hazard. Other anthropometric measures and their relation to obesity have been studied, each with its advantages and limitations. In this work, we introduce a new anthropometric measure (called Surface-based Body Shape Index, SBSI) that accounts for both body shape and body size, and evaluate its performance as a predictor of all-cause mortality.

### Methods and Findings

We analyzed data on 11,808 subjects (ages 18–85), from the National Health and Human Nutrition Examination Survey (NHANES) 1999–2004, with 8-year mortality follow up. Based on the analysis, we introduce a new body shape index constructed from four important anthropometric determinants of body shape and body size: body surface area (BSA), vertical trunk circumference (VTC), height (H) and waist circumference (WC). The surface-based body shape index (SBSI) is defined as follows: (1) SBSI has negative correlation with BMI and weight respectively, no correlation with WC, and shows a generally linear relationship with age. Results on mortality hazard prediction using both the Cox proportionality model, and Kaplan-Meier curves each show that SBSI outperforms currently popular body shape indices (e.g., BMI, WC, waist-to-height ratio (WHtR), waist-to-hip ratio (WHR), A Body Shape Index (ABSI)) in predicting all-cause mortality.

### Conclusions

We combine measures of both body shape and body size to construct a novel anthropometric measure, the surface-based body shape index (SBSI). SBSI is generally linear with age, and increases with increasing mortality, when compared with other popular anthropometric indices of body shape.

**Citation: **Rahman SA, Adjeroh D (2015) Surface-Based Body Shape Index and Its Relationship with All-Cause Mortality. PLoS ONE 10(12):
e0144639.
doi:10.1371/journal.pone.0144639

**Editor: **Li Wang,
Peking Union Medical College, CHINA

**Received: **October 11, 2014; **Accepted: **November 20, 2015; **Published: ** December 28, 2015

**Copyright: ** © 2015 Rahman, Adjeroh. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited

**Data Availability: **All NHANES data files are available from the CDC webpage (from 1999–2003 with mortality followup), URL: http://wwwn.cdc.gov/nchs/nhanes/search/nhanes99_00.aspx.

**Funding: **The authors have no support or funding to report.

**Competing interests: ** The authors have declared that no competing interests exist.

## Introduction

Obesity, with its dual complications of diabetes mellitus and cardiovascular disease (CVD), has emerged as a major public health challenge [1–3]. Obesity is identified by the World Health Organization (WHO) as a global epidemic [4]. In the US, obesity prevalence remains high at 35.7% of the adult population [5], while 68% are classified as obese or overweight [1], with the highest rates being found among the populations that are poor, have lower education, and are minority groups [1]. The picture for childhood and adolescent obesity is no better, with 16.9% obesity prevalence, and 31.8% classified as obese or overweight [5], and thus at the risk of developing insulin resistance, dyslipidemia, or hypertension at an early age [6]. This trend is mirrored by the high incidence of diabetes, which has shown a similarly high prevalence rates [7]. The problem of obesity is attributed to the issue of imbalance between energy intake and energy expenditure in the body [8]. The problem is directly connected to the quantity of adipose depots (body fat). Adiposity is associated with increased risk of many chronic diseases in the general population [9–13]. Obesity is known to be associated with diabetes, and various forms of cardiovascular disease (CVD). Other associated complications include depression, mobility issues, some forms of cancer [14], sleep apnea [15], osteoarthritis, among others (see [8] for a review).

Many different anthropometric measures have been used to assess adiposity. The body mass index (BMI) is one of the best known indices of relative adiposity or excess body weight in the association of body composition with mortality. Individuals are often grouped into BMI categories [4, 16] (underweight (*BMI* < 18.5), normal weight (18.5 ≤ *BMI* < 25), overweight (25 ≤ *BMI* < 30), obese I (30 ≤ *BMI* < 35), obese II (35 ≤ *BMI* < 40), and obese III (*BMI* ≥ 40)). Risk of CVD and diabetes tends to increase with increasing BMI. The association of BMI with mortality in the general population is usually found to exhibit a U-shaped [17, 18] or J-shaped [19, 20] curve. Using BMI-defined categories Flegal et al [18] showed, that obese and underweight individuals had a higher death rate, while normal weight and overweight individuals had a similar relative mortality risk. Some have hypothesized that the non-linear relationship observed between BMI and mortality may be a consequence of BMI being a composite of both fat and fat-free mass [21, 22], not simply a surrogate for overall adiposity. These observations point to the core limitation of BMI as a measure of adiposity. Several studies have shown that adjustment for waist circumference, a surrogate for abdominal adiposity [23–25], eliminates or attenuates BMI’s nonlinear relationship with mortality [26, 27]. The ABSI (A Body Shape Index, defined as *ABSI* = *WC*/(*BMI*^{2/3} * *H*^{1/2}) which places more emphasis on waist circumference was proposed by Krakauer and Krakauer [28] as an alternative to the BMI, resulting in a better prediction of mortality hazard. Various other one dimensional (1D) anthropometric measures (e.g., waist circumference (WC), hip circumference (HC), skin folds (SFs)), and their relation to obesity have also been studied. Example, the waist-to-hip ratio (WHR) is a better indicator of ischemic heart disease mortality [29], while the waist-to-height ratio (WHtR) provides a better predictor for death, heart attack and stroke [30]. Ohrvall et al [31] and Pouliot et al [32], showed sagittal abdominal diameter to be a better measure of the accumulation of visceral adipose tissue and cardiovascular risk. Beyond 1D measures, there are also studies linking obesity-related diseases with 2D measures (e.g., body surface area (BSA) [33]), and 3D measures [34–36], (e.g., body volume index (BVI) [22, 37]).

Results in [28] showed that ABSI produced better results than both BMI and WC in terms of all-cause-mortality hazard prediction. More recent studies, however, show that ABSI does not perform better than WC for diabetes mellitus (DM) prediction [38]. He et al [38], showed that for the Chinese population, the three measures WC, BMI, and ABSI showed similar predictive abilities. Zhang et al [39], showed ABSI to be a weak predictor for the risk of cardiovascular diseases (CVD), or the problem of Metabolic Syndrome (MetS). Clearly, no single measure can capture all aspects of the general problem of obesity and its related diseases. In this work, we first introduce a new anthropometric measure (called Surface-based Body Shape Index, SBSI) that accounts for both body shape and body size. Then, we evaluate the proposed measure as a predictor of all-cause-mortality, and compare its performance with other popular body shape indices, namely BMI, WC, and ABSI.

## Materials and Methods

### Datasets

We used mortality data combined with anthropometric data from the National Health and Human Nutrition Examination Surveys (NHANES) 1999–2004 [40–42]. NHANES employs a complex cluster design to sample members of the civilian USA population who are not institutionalized. NHANES uses stratified multistage probability to sample the data. Mortality information from public-use mortality files is linked to the National Death Index (NDI). Since not all the data contained mortality information we excluded those individuals that do not have data on mortality. Ethnicity included white, black, Mexican and others. Anthropometric measurements included BMI, height, weight, and waist circumference. We used the NHANES mobile examination center sample. The mobile examination center used trained examiners who used standardized protocols to measure the anthropometric parameters. Mortality data based on NDI were available in 2006. After refining, we obtained 11,808 individuals with 701 deaths during the 2–8 years of follow-up (1999–2006).

We also used data from the Civilian American and European Surface Anthropometry Resource (CAESAR) [43]. CAESAR project was a survey of the civilian populations from four countries namely the United States of America (USA), Canada, the Netherlands, and Italy. The survey was carried out by the U.S. Air Force, resulting in complete 3-D models of each civilian subject. The 3-D surface anthropometry was performed using three scanned poses using the cyberware 3D whole-body scanner [44]. The CAESAR dataset also includes manual hand measurements of the various anthropometric attributes, recorded as 1D information. For our purpose, we used the 1D datasets from the CEASAR survey, which contains 2400 US and Canadian civilians, ages 18–65 (http://store.sae.org/caesar/). We selected 45 key human body measurements, as reported by Adjeroh et al [45] and Cao et al [46]. From our analysis, the key measurements shared by both datasets tend to have similar general statistics. For example, the mean and standard deviation were observed as follows: height (NHANES 167.7 ± 10.1; CAESAR 170.46 ± 10.2), waist circumference (NHANES 92.2 ± 13.2; CAESAR 84.8 ± 14.4), weight (NHANES 74 ± 15.8; CAESAR 77 ± 19.8), BMI (NHANES 26.2 ± 4.7; CAESAR 26.3 ± 5.7). Apart from the prediction of VTC for NHANES samples based on learned parameters from CAESAR, all other analyses are based on the NHANES dataset.

### Study Variables

In the CAESAR study [43], data collection was a three-step process: in-processing/demographics; traditional hand measurements with tape and calipers; and 3D whole-body scanning stations. All measurements were taken with participants wearing light clothes and without shoes. For height, subject stands fully erect with weight distributed equally on both feet, with both arms hanging freely downwards. Thigh circumference was measured on a seated subject. Triceps skinfold is the thickness of the skinfold overlaying the triceps muscle. This was measured on the back of the upper arm, between the tip of the shoulder and the elbow while the subject’s arm is bent 90°. VTC was measured using a tape from the shoulder, through the crotch, and back to the shoulder while the subject stands fully erect with the weight distributed equally on both feet and the arms hanging freely downwards. Waist circumference is the maximum circumference of the waist that can be measured using a tape measure, which starts at the top of subject’s hip bone, then all the way around level with his/her belly button. Height, circumferences, and length measurements were made to the nearest 0.1 cm, while weight was measured to the nearest kilogram.

In the NHANES study [40–42], anthropometric measurements were taken by trained personnel. Height was obtained using a digital meter. Subjects wore a light examination gown before measuring their weight on a digital scale. Waist circumference was measured just above the uppermost lateral border of the ilium. A key component of the proposed SBSI is the vertical trunk circumference (VTC). Given that NHANES does not contain information on the VTC for its subjects, we first learned the regression parameters for predicting the VTC using the CAESAR dataset. Then, we applied the learned parameters on the samples from NHANES to predict their VTC. Since the two datasets have similar overall statistics, we can rely on the results of the prediction for subjects in NHANES. Based on the measures, we computed the BMI using the standard formula: *BMI* = *W*/*H*^{2} (unit *kg*/*m*^{2}), where W is weight (kg), and H is height (m). The body surface area (BSA) is assessed following Shuter and Aslani [47]: *BSA* = 0.00949 × *W*^{0.441} × *H*^{0.655}. BMI obesity categories were computed following WHO definitions [56, 62]: underweight (*BMI* < 18.5), normal (18.5 ≤ *BMI* < 25), overweight (25 ≤ *BMI* < 30), obese I (30 ≤ *BMI* < 35), obese II (35 ≤ *BMI* < 40), and obese III (*BMI* ≥ 40).

### Surface-based Body Shape Index (SBSI)

The BMI provides a simple coarse measure of the body shape. Two people in the same BMI category could have very different body shapes, and different body sizes. The distribution of body weight, rather than the absolute weight, is a key factor in predicting health risk. A person with much of the body weight around the midsection is at a much greater risk of disease and early mortality, when compared with another person that has weight better distributed peripherally (especially in lower body) [48]. This observation relates to the so-called ‘apple-shaped vs. pear-shaped’ phenomena, whereby the waist-to-hip ratio (WHR) is used to determine whether a person is apple-shaped (*WHR* < 0.8 for women, *WHR* < 0.9 for men), or pear-shaped (*WHR* ≥ 0.8 for women, *WHR* ≥ 0.9 for men). See [48]. The waist circumference (WC) is often combined with the BMI for an improved assessment of body shape [28]. Other studies used waist-to-height ratio (WHtR) as a shape index [49]. In addition to body shape, the body size is also another important factor. While indices such as BMI, ABSI, waist-to-height ratio (WHtR) measure body shape, others such as BSA, WC, H, and VTC provide some indication of body size. The body surface area (BSA) provides a measure of the body size, while the VTC measures both the body size, and body shape. In this work, we consider both body shape and body size simultaneously, and thus combine the BSA and VTC with height and WC to develop a new surface-based body shape index.

To investigate the significance of the BSA and VTC, we analyzed their relationship with height and waist circumference, for a given BMI category, using the NHANES dataset. The results are shown in Fig 1. It can be observed that, at a given height, obese individuals tend to have higher BSA, while those that are underweight tend to have a lower BSA. At a given height, the BSA tends to increase steadily with BMI (Fig 1a). VTC and height show a similar behavior at given BMI categories (Fig 1b). The relationship between BSA and WC (or VTC and WC) is not as clear. Unlike the clear linear association between BSA (or VTC) and height, for a given BMI category, BSA (VTC) has a non-linear relationship with WC, for a given BMI. Yet, the different BMI categories are evident from the graphs (Fig 1c and 1d). The underweight group clustered in mainly the bottom left quadrant, while the obese III category clustered around the top right quadrant.

The BSA and height, and VTC and height can predict the BMI categories (a, b). BSA and WC (and VTC and WC) show a non-linear relationship for a given BMI category (c, d).

### SBSI Construction

Different formulae have been proposed for estimating the body surface area (BSA), based mainly on the weight and height. In a survey of different BSA predictors [50], the Shuter and Aslani method [47] was shown to provide an overall best performance. Thus, in this work, we adopt this method to predict BSA as follows:
(2)
where W = weight in kilograms, and H = height in meters. For VTC, we first identified common anthropometric measurements between the CAESAR and NHANES datasets. Then we performed simple linear regression using the samples in CAESAR and subsequently applied regression learning to predict the VTC for the samples in the NHANES database. The VTC (in cm) is predicted using the formula:
(3)
where AC = arm circumference (cm), H = height (cm), SS = subscapular skin fold (cm), TC = thigh circumference (cm), TS = triceps skinfold (cm), UAL = upper arm length (cm), WC = waist circumference (cm), W = weight (kg). This prediction resulted in error measure (*R*^{2} = 0.9217, p-value (P) = 2.2 × 10^{−16}) using the CAESAR dataset.

We then combine the BSA and VTC with the height and waist circumference by using linear regression on log(*BSA* × *VTC*) as a function of log(*H*) and log(*WC*) for the entire database:
(4)
The error measure for this prediction was (*R*^{2} = 0.9, *P* = 2.2 × 10^{−16}). From the above, we can infer the relationship:
(5)
Taking ratios of the two sides, we define the Surface-based Body Shape Index (SBSI) as follows:
(6)

### Statistical Analysis

We analyzed the data separately for male and female subjects, and for their combination. Table 1 shows the characteristics of the study participants for NHANES dataset. The corresponding data for the CAESAR dataset is provided as Supplementary Material in S1 Table. The sample mean for SBSI (using NHANES) is 0.10718±0.00627, with a minimum of 0.08218, and a maximum of 0.14228. For CAESAR dataset, we observed mean SBSI of 0.10644±0.006092, a minimum of 0.07437, and a maximum of 0.1386.

Table 2 shows the correlation between the SBSI and other anthropometric body indices. The table shows the correlation using direct measurements for both Pearson’s *ρ* (upper half), and Kendall’s *τ* (lower half). For a given measurement value *x*, its *z*-score is computed as *z*(*x*) = (*x* − *μ*)/*σ*, where *μ* and *σ* are the mean and standard deviation for the measurement. SBSI has high correlation with ABSI, low correlation with WC and height, and negative correlation with BMI and weight. The reason has a high correlation with SBSI might be because of the fact that both ABSI and SBSI use WC, and H in similar roles in their respective formulae.

We used Cox proportionality mortality hazard modeling [51, 52] to quantify the association of the proposed SBSI and other anthropometric measures (ABSI, BMI, and WC) with all-cause mortality. Under the Cox model, the relationship between hazard and the covariates is described by considering the logarithm of the hazard as a linear function of the variables. Following the Poisson model, this can be expressed by using exponentiation on the covariate terms [52]:
(7)
where, *h*_{0} is the baseline hazard, *β*_{0} and *β*_{1} are coefficients influencing the covariates *x*. This is often generalized as follows:
(8)
where *α* are the parameters influencing the baseline hazard. In our approach we modeled the log death rate as a nonparametric function of time (months of follow-up from the interview) and coefficients are fitted which multiply the value of the predictor variables. Although predictors can be entered as either continuous or discrete, we used predictor’s *z*-score as continuous variables for generalization. Previous studies suggest that using *z*-score in the hazard model produce better results [28]. We calculated mortality risk associated with each anthropometric measurement separately for male and female subjects, and later for all subjects in the dataset. Then we divided the dataset using BMI categories to test the range of applicability of our proposed SBSI and also how it compares with other existing body shape indices. We used the *R*^{2} statistic to measure how successful the model is in explaining the variation of the data.

To further study the predictive capabilities of SBSI and to compare with other body shape indices, we constructed and analyzed the Kaplan-Meier (KM) curves [53] using each measure. The Kaplan-Meier estimate of the survival function is a non-parametric method of estimating survival from data. It is very popular because it makes only very weak assumptions about the data. In medical research, it is used to measure the fraction of patients surviving for a certain amount of time after treatment. Let *S*(*t*) be the probability that a member from a given population will have a lifetime exceeding t. For a sample of size *N* from this population, let the observed times until death of the *N* sample members be *t*_{1} ≤ *t*_{2} ≤ *t*_{3} ≤ … ≤ *t*_{N}. Corresponding to each *t*_{i} is *n*_{i}, the number “at risk” just prior to time *t*_{i}, and *d*_{i}, the number of deaths at time *t*_{i}. The Kaplan–Meier estimator is the nonparametric maximum likelihood estimate of , where is a product of the form
(9)
We performed analysis using KM survival curve estimates for all the data, and separately for all female, and all male. Then we did more rigorous study based on BMI categories. We used the log-rank test to compare the survival distributions obtained using different shape indices. The log-rank test tries to distinguish between Kaplan-Meier curves to see if they are statistically equivalent. The output of the test is a *χ*^{2}-distance, and the P-value associated with the distance. Higher *χ*^{2}-distances and low P-values indicate a better separation between the curves, and hence a better performance in mortality modeling. All statistical analyses were performed using the R Language (ver. 3.0.3, The R Foundation for Statistical Computing, Vienna, Austria). We considered *P* ≤ 0.05 to be statistically significant.

## Results

### Higher SBSI with Increasing Age

The SBSI increases generally with increasing age. Fig 2 shows how the SBSI and three other anthropometric measures vary with age for both male and female. Subjects in our NHANES dataset had age ranges between 18–85 years. Mean SBSI increases consistently (generally linearly) for male subjects. However, for female subjects, the mean goes up from about ages 18 to 24 then goes down till about age 30; between ages 30 and 40, the mean SBSI did not have a definite pattern for females, going up and then down. After this point, the SBSI generally increased with age. For WC, ABSI and SBSI, the mean values for males were clearly separated from those for females, with the value for males being generally greater. For the BMI, this distinction was not as clear. Unlike ABSI and SBSI that had a generally linear relationship with age, the BMI and WC had an inverted U-like shape, with the turning points around age 75 for WC, and age 70 for BMI.

### Higher Mortality Hazard for Increasing SBSI

Fig 3 shows the variation of the relative death rate with SBSI using their *z*-scores. The figure shows that the relative death rate increases almost exponentially with increasing values of SBSI. The variability in the mortality hazard prediction also seems to increase with increasing SBSI values. The results in this figure are consistent with known results that relative death rate is generally higher for male than female subjects. In Fig 3(a) the relative death rate for female was almost similar until about the 50th percentile (average 1.3) then it went up (from 4 to 14). For male (Fig 3b) average death rate was 1.02 until about the 35th percentile, after that it grew exponentially (from 3 to 28).

### Improved Modeling for All-Cause Mortality using SBSI

The proposed surface-based body shape index shows substantial improvements in mortality modeling, when compared with popular body shape indices. Table 3 shows the summary performance in mortality hazard modeling for SBSI, ABSI, BMI, and WC. The hazard ratio (HR) for SBSI was 2.287 for all, 2.019 for female and 2.456 for male. For all measures, the results are based on using their *z*-scores as a continuous variable, rather than the original value.

Table 4 shows the corresponding results in terms of the *χ*^{2}-distance when using the logrank test to analyze the KM survival curves for each body shape index. The *χ*^{2}-distance for SBSI was 570 for all, 147.68 for female and 434.372 for male. Here the analyses was done on the quartiles labeled as 1st Q, 2nd Q, etc. in Fig 4. From the table, SBSI performs significantly better than waist circumference and ABSI. Clearly, the BMI was unable to show a distinction in the survival rates for the quartiles, given its non-linear relationship with mortality-hazard.

The SBSI shows a better prediction performance than other body shape measures (with more separation between the curves, and less crossovers). 1st Q, 2nd Q, etc. denote respectively 1st quartile, 2nd quartile, etc.

Fig 4 shows the detailed Kaplan-Meier curves for SBSI and three other key anthropometric body shape indices. A given variable is a good mortality predictor if the Kaplan-Meier curves are easily distinguishable (more distance between them), and the variable gives a reasonable performance from low to high levels, with less crossing between curves. SBSI performs very well in distinguishing the proportion of survivors over time (months) since examination. From the figure, it is clear that ABSI and SBSI are much better than WC and BMI in predicting survival, with the SBSI being slightly better than ABSI. The difference between ABSI and SBSI is more evident using quantitative measures, e.g., the *χ*^{2}-distance between their respective KM curves, as captured by the logrank test (Table 4). More detailed results using the hazard ratio with BMI categories are described below (see Table 5). The corresponding results for using the log-rank test to analyze the KM plots are given in Table 6, Figs 5 and 6.

a: ABSI (male); b: ABSI (female); c: SBSI (male); d: SBSI (female). As expected, both measures indicate that female subjects have better survival rates when compared with male subjects. SBSI shows an overall better prediction performance than ABSI. 1st Q, 2nd Q, etc. denote respectively 1st quartile, 2nd quartile, etc.

a: ABSI (male); b: ABSI (female); c: SBSI (male); d: SBSI (female).

### Mortality Hazard using SBSI on BMI Categories

To further investigate the performance of SBSI in mortality modeling, we considered the mortality hazard ratio (HR) using the SBSI for each BMI category. Table 5 shows the results. In general, the hazard ratios using SBSI does not necessarily increase monotonically with increasing BMI values (BMI increases from underweight category to obese III). For instance, considering all subjects, mortality hazard ratio increased from 2.352 (*P* < 0.0001) for the underweight category, to 2.799 (*P* < 0.0001) for normal weight, and then decreased to 2.601 (*P* < 0.0001) for overweight, increasing again to 2.952 (*P* < 0.0001) for obese I. A similar trend is observed for female-only, and for male-only subjects. The table also shows the corresponding mortality hazard ratios using various other anthropometric shape indices. From the table, ABSI and the proposed SBSI tend to provide the best performance in most cases, followed by WC. Though ABSI provided the overall best result using all subjects (ABSI: HR 2.328, *P* < 0.0001; SBSI: HR 2.287, *P* < 0.0001), when split into BMI categories, SBSI provided a better performance over ABSI for all the BMI categories. SBSI was the overall best on each BMI category, except for underweight and normal weight categories (which had WC as the best performer). Using all subjects, ABSI performed better than SBSI on male subjects (ABSI: HR 2.682, *P* < 0.0001; SBSI: HR 2.456, *P* < 0.0001), while SBSI performed better on female subjects (ABSI: HR 1.999, *P* < 0.0001; SBSI: HR 2.019, *P* < 0.0001). However, again when split into BMI categories, for male subjects, ABSI outperformed SBSI only in one category–obese II (ABSI: HR 4.900, *P* = 0.004; SBSI: HR 4.080, *P* < 0.006). SBSI was the overall best in two categories, while WC was the overall best in two other categories. For female subjects, with BMI categories, SBSI provided the best results for 5 of the 7 categories, while WC reported best results for the other two categories.

To further study the performance of SBSI and other anthropometric measures using BMI categories, we analyzed the Kaplan-Meier survival curves obtained using each measure, when applied separately to subjects in each BMI category. Table 6 shows the results of this analysis. Similar to the mortality hazard, SBSI logrank result (*χ*^{2}-distance) does not increase monotonically with increasing BMI. For example, considering all subjects, the *χ*^{2}-distance increased from 11.947(P = 0.008) for the underweight category, to 296.451 (*P* < 0.0001) for normal weight and then decreased to 202.795 (*P* < 0.0001) for overweight, decreasing further to 130.434 (*P* < 0.0001) for obese I. We observe a similar trend for female-only, and for male-only subjects as well. The table also shows the results of the logrank test on other anthropometric shape indices. From the table, SBSI tends to provide the best performance in most cases followed by ABSI, WC. In general SBSI performed better than all the other anthropometric measures tested. Performing the logrank test for all subjects we get *χ*^{2}-distance 570 (*P* < 0.0001) whereas for other measures only ABSI (*χ*^{2}-distance 551 (*P* < 0.0001)) was close. For all-female (*χ*^{2}-distance 147.688, *P* < 0.0001) and all-male (*χ*^{2}-distance 434.372, *P* < 0.0001) SBSI provided overall best result. Also after splitting into BMI categories, SBSI provided the best performance as well. For all-male, all-female, and all subjects SBSI outperformed ABSI in all BMI categories except underweight (See Table 6). These results suggest that SBSI is the best anthropometric measure and distinguishes the Kaplan-Meier curves better than the other existing body measures tested.

From the results, ABSI and SBSI produced the overall best results using the KM curves on BMI categories. To further analyze the differences between ABSI and SBSI, we considered two BMI categories. Figs 5 and 6 show the KM plots for two BMI categories (overweight, and obese I), for both ABSI and SBSI. As expected, both measures indicate that female subjects generally have better survival rates when compared with male subjects. SBSI produced an overall better performance in modeling survival over time, when compared with ABSI.

## Discussion

Our proposed surface-based body shape index (SBSI) is constructed based on four key anthropometric determinants of body shape and body size: body surface area (BSA), vertical trunk circumference (VTC), height (H) and waist circumference (WC). Considered at a given height, SBSI depends on WC divided by BSA and VTC. While the BSA measures the whole body, WC and VTC measure the trunk region, with WC measured horizontally, while VTC is measured vertically. More importantly, both WC and VTC are strongly associated with abdominal fat. Previous studies [54–57] show that mortality hazard is highly related to abdominal fat. Given that SBSI has a strong association with mortality hazard, and given its definition based on WC and VTC, we suspect that SBSI will also have a significant association with abdominal fat or body volume around the waist or the trunk.

Applying SBSI initially gives reasonable performance when compared with existing body shape measures. In particular, it produced a performance that is similar to that of ABSI on most cases, and better for some BMI categories. However, given the SBSI formula, it is natural to consider some variations on the definition of SBSI. For instance, one simplification would be to remove the fractional exponents on the variables, approximating them with integral exponents. Using this, we get a simpler formula (denoted SBSI*), whose values have no units: (10)

Not surprisingly, this simplified formula shows very competitive performance, producing results that are generally close to the original SBSI. See the rows denoted SBSI* in the tables (Tables 5 and 6). This competitive performance implies that SBSI* could be used in place of SBSI, depending on available computational resources, since SBSI* is just a simple unitless ratio, and easy to compute.

The measurement protocol can influence the relationship among measures for two different studies [55]. And differences between the populations involved in the study could be significant. For example, conclusions from a study based on anthropometric measurements on a Chinese population may not completely hold when applied to, say, a US population; In our work, we used two different datasets, (CAESAR and NHANES), with some differences in the way the measurements were acquired. Since we used regression parameters learned from CAESAR to apply to NHANES data, we first verified that the two data sets had similar general statistics. Participants in both studies were similar (mostly, North American, and Caucasian). The mean and standard deviation for some key attributes are as follows: height (NHANES 167.72 ± 10.1cm, CAESAR 170 ± 10.25cm), weight (NHANES 74 ± 15.8 kg, CAESAR 77 ± 19.79kg), waist circumference (NHANES 92 ± 13.23cm, CAESAR 84.77 ± 14.43cm). Thus, at least, for these key measurements, the values from the two datasets are within one standard deviation of each other.

Age is an important factor in analyzing the mortality hazard in a population. Although the SBSI generally increased with increasing age, it was still not clear exactly how age will impact the mortality hazard modeling. To further investigate this potential connection, we categorized the study population into different age ranges: < 20 (1638 people with mortality count 10), 20–35 (2937 people with mortality count 14), 36–50 (2501 people with mortality count 51), 51–70 (2678 people with mortality count 178), and > 70 (2054 people with mortality count 448). S2 and S3 Tables (Supplementary Materials) respectively, show the results for using the Cox proportionality hazard model and log-rank test on the KM curves, for mortality studies using the age categories. From the results, when using all subjects, the SBSI provided a more accurate model of the mortality hazard for people older than 35. (We ignore results for those < 20 and 20–35 group, since these groups do not contain enough mortality information). For cases of all, female-only, and male-only, SBSI performed very well on both hazard ratio and log-rank test, for the age categories 36–50, 51–70, and > 70. For the 51–70 group, for all people, the hazard ratio was 1.626. The log-rank test resulted in a *χ*^{2}-distance of 34.058 (*P* < 0.0001), almost twice as the second best ABSI (17.620, *P* < 0.0001). Thus, the KM-curves for this case is expected to be more easily distinguishable for SBSI.

In this study, we have reported results on the prediction of all-cause mortality using the proposed surface-based body shape index. We applied the index on samples from the NHANES dataset (age range 18–85), using standard BMI categories. The 11808 people in our dataset were grouped as follows: 298 underweight, 4756 normal weight, 4527 overweight, 1715 obese I, 412 obese II, 100 obese III. Our results showed that the mortality hazard as measured by SBSI (and also ABSI) does not necessarily increase monotonically with BMI. For instance, the overweight category (HR 2.264, *P* < 0.0001) showed a lower hazard ratio than the normal weight category (HR 2.799, *P* < 0.0001). Similarly, the underweight group had a lower all-cause mortality hazard (HR 2.352, *P* < 0.0001) than the normal weight group. The hazard ratio increased for obese I category (HR 2.952, *P* < 0.0001) and obese II category (HR 3.970, *P* < 0.0001). This result is consistent with previous studies on mortality hazard and BMI categories [58, 59]. We did not observe a consistent increase in mortality for increasing BMI categories. Our results using the surface-based body shape index are also consistent with previous observations of lower mortality among slightly obese and overweight groups of people [60, 61] when compared with the normal weight category. Doehner et al, [62] discussed this phenomenon, in terms of the “obesity paradox”.

### Limitations of the approach

We identify some limitations in our study. One potential problem is the lack of control for certain demographics, for instance, smoking and non-smoking status, pregnancy, socio-economic status, ancestry, etc. While these may be valid topics for future work, previous studies showed that adjusting for smoking as a variable does not significantly affect the results [63]. Similarly, pregnancy was not found to significantly impact the results.

The formulation of SBSI consists of VTC which is not available in the NHANES dataset. Thus, prediction parameters for VTC were estimated using the CAESAR dataset, and applied on subjects in the NHANES dataset. NHANES study consists of only US citizens, but CAESAR has subjects from the US, Canada, and Europe. Variability in the data collection protocols, and the general make-up of the subjects could be important sources of error. Given that both datasets are collected by trained professionals [40–43] and not self-reported, differences due to the collection protocol can be assumed to be minimal. In terms of content, both the datasets are statistically similar. For the same anthropometric attribute the average measurements from the two datasets were generally within one standard deviation of each other. See Table 1 and S1 Table (Supplementary Materials).

## Supporting Information

### S1 Table. Key anthropometric attributes for study participants (using the CAESAR dataset).

doi:10.1371/journal.pone.0144639.s001

(DOCX)

### S2 Table. Results for Cox Proportional Hazard applied to different age categories.

doi:10.1371/journal.pone.0144639.s002

(DOCX)

### S3 Table. Log-rank test results for different age category.

doi:10.1371/journal.pone.0144639.s003

(DOCX)

## Author Contributions

Conceived and designed the experiments: SR DA. Performed the experiments: SR. Analyzed the data: SR DA. Contributed reagents/materials/analysis tools: SR DA. Wrote the paper: SR DA. Motivation and idea: SR DA.

## References

- 1. Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999–2008. JAMA. 2010;303(3):235–241. doi: 10.1001/jama.2009.2014. pmid:20071471
- 2. Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA. 2003;289(1):76–79. doi: 10.1001/jama.289.1.76. pmid:12503980
- 3. Ogden CL, for Health Statistics (US) NC, et al. Prevalence of obesity in the United States, 2009–2010. US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics; 2012. doi: 10.1037/e372342004-001
- 4.
WHO. Obesity: preventing and managing the global epidemic. 894. World Health Organization; 2000.
- 5. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of obesity and trends in body mass index among US children and adolescents, 1999–2010. JAMA. 2012;307(5):483–490. doi: 10.1001/jama.2012.40. pmid:22253364
- 6. Raghuveer G. Lifetime cardiovascular risk of childhood obesity. The American Journal of Clinical Nutrition. 2010;91(5):1514S–1519S. doi: 10.3945/ajcn.2010.28701D. pmid:20335556
- 7.
IEEE Conference on Decision and Control and European Control Conference @ONLINE; 2011. Available from: http://control.disp.uniroma2.it/cdcecc2011/; http://www.cdc.gov/BRFSS/
- 8. Racette SB, Deusinger SS, Deusinger RH. Obesity: Overview of prevalence, etiology, and treatment. Physical Therapy. 2003;83(3):276–288. pmid:12620091
- 9. Chan JM, Rimm EB, Colditz GA, Stampfer MJ, Willett WC. Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care. 1994;17(9):961–969. doi: 10.2337/diacare.17.9.961. pmid:7988316
- 10. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults. New England Journal of Medicine. 2003;348(17):1625–1638. doi: 10.1056/NEJMoa021423. pmid:12711737
- 11. Colditz GA, Willett WC, Rotnitzky A, Manson JE. Weight gain as a risk factor for clinical diabetes mellitus in women. Annals of Internal Medicine. 1995;122(7):481–486. doi: 10.7326/0003-4819-122-7-199504010-00001. pmid:7872581
- 12. Eckel RH, Krauss RM, et al. American Heart Association call to action: Obesity as a major risk factor for coronary heart disease. Circulation. 1998;97(21):2099–2100. doi: 10.1161/01.CIR.97.21.2099. pmid:9626167
- 13. Kenchaiah S, Evans JC, Levy D, Wilson PW, Benjamin EJ, Larson MG, et al. Obesity and the risk of heart failure. New England Journal of Medicine. 2002;347(5):305–313. doi: 10.1056/NEJMoa020245. pmid:12151467
- 14. Gallicchio L, McSorley MA, Newschaffer CJ, Huang HY, Thuita LW, Hoffman SC, et al. Body mass, polymorphisms in obesity-related genes, and the risk of developing breast cancer among women with benign breast disease. Cancer Detection and Prevention. 2007;31(2):95–101. doi: 10.1016/j.cdp.2007.02.004. pmid:17428620
- 15. Onat A, Hergenç G, Yüksel H, Can G, Ayhan E, Kaya Z, et al. Neck circumference as a measure of central obesity: associations with metabolic syndrome and obstructive sleep apnea syndrome beyond waist circumference. Clinical Nutrition. 2009;28(1):46–51. doi: 10.1016/j.clnu.2008.10.006. pmid:19010573
- 16. Flegal KM, Kit BK, Orpana H, Graubard BI. Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA. 2013;309(1):71–82. doi: 10.1001/jama.2012.113905. pmid:23280227
- 17. Allison DB, Zhu S, Plankey M, Faith MS, Heo M. Differential associations of body mass index and adiposity with all-cause mortality among men in the first and second National Health and Nutrition Examination Surveys (NHANES I and NHANES II) follow-up studies. International Journal of Obesity and Related Metabolic Disorders: Journal of The International Association for the Study of Obesity. 2002;26(3):410–416. doi: 10.1038/sj.ijo.0801925.
- 18. Flegal KM, Graubard BI, Williamson DF, Gail MH. Excess deaths associated with underweight, overweight, and obesity. JAMA. 2005;293(15):1861–1867. doi: 10.1001/jama.293.15.1861. pmid:15840860
- 19. Lew EA, Garfinkel L. Variations in mortality by weight among 750,000 men and women. Journal of Chronic Diseases. 1979;32(8):563–576. doi: 10.1016/0021-9681(79)90119-X. pmid:468958
- 20. Manson JE, Willett WC, Stampfer MJ, Colditz GA, Hunter DJ, Hankinson SE, et al. Body weight and mortality among women. New England Journal of Medicine. 1995;333(11):677–685. doi: 10.1056/NEJM199509143331101. pmid:7637744
- 21. Allison DB, Faith MS, Heo M, Kotler DP. Hypothesis concerning the U-shaped relation between body mass index and mortality. American Journal of Epidemiology. 1997;146(4):339–349. doi: 10.1093/oxfordjournals.aje.a009275. pmid:9270413
- 22. Bigaard J, Frederiksen K, Tjønneland A, Thomsen BL, Overvad K, Heitmann BL, et al. Body fat and fat-free mass and all-cause mortality. Obesity Research. 2004;12(7):1042–1049. doi: 10.1038/oby.2004.131. pmid:15292467
- 23. Han T, McNeill G, Seidell J, Lean M. Predicting intra-abdominal fatness from anthropometric measures: the influence of stature. International Journal of Obesity. 1997;21(7):587–593. doi: 10.1038/sj.ijo.0800446. pmid:9226490
- 24. Janssen I, Heymsfield SB, Allison DB, Kotler DP, Ross R. Body mass index and waist circumference independently contribute to the prediction of nonabdominal, abdominal subcutaneous, and visceral fat. The American journal of clinical nutrition. 2002;75(4):683–688. pmid:11916754
- 25. Snijder M, Van Dam R, Visser M, Seidell J. What aspects of body fat are particularly hazardous and how do we measure them? International Journal of Epidemiology. 2006;35(1):83–92. doi: 10.1093/ije/dyi253. pmid:16339600
- 26. Bigaard J, Tjønneland A, Thomsen BL, Overvad K, Heitmann BL, Sørensen TI. Waist Circumference, BMI, Smoking, and Mortality in Middle-Aged Men and Women. Obesity Research. 2003;11(7):895–903. doi: 10.1038/oby.2003.123. pmid:12855760
- 27. Kanaya AM, Vittinghoff E, Shlipak MG, Resnick HE, Visser M, Grady D, et al. Association of total and central obesity with mortality in postmenopausal women with coronary heart disease. American journal of epidemiology. 2003;158(12):1161–1170. doi: 10.1093/aje/kwg271. pmid:14652301
- 28. Krakauer NY, Krakauer JC. A new body shape index predicts mortality hazard independently of body mass index. PLoS One. 2012;7(7):e39504. doi: 10.1371/journal.pone.0039504. pmid:22815707
- 29. Mørkedal B, Romundstad PR, Vatten LJ. Informativeness of indices of blood pressure, obesity and serum lipids in relation to ischaemic heart disease mortality: the HUNT-II study. European Journal of Epidemiology. 2011;26(6):457–461. doi: 10.1007/s10654-011-9572-7. pmid:21461943
- 30. Schneider HJ, Friedrich N, Klotsche J, Pieper L, Nauck M, John U, et al. The predictive value of different measures of obesity for incident cardiovascular events and mortality. The Journal of Clinical Endocrinology & Metabolism. 2010;95(4):1777–1785. doi: 10.1210/jc.2009-1584.
- 31. Ohrvall M, Berglund L, Vessby B. Sagittal abdominal diameter compared with other anthropometric measurements in relation to cardiovascular risk. International Journal of Obesity and Related Metabolic Disorders: Journal of the International Association for the Study of Obesity. 2000;24(4):497–501. doi: 10.1038/sj.ijo.0801186.
- 32. Pouliot MC, Després JP, Lemieux S, Moorjani S, Bouchard C, Tremblay A, et al. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. The American Journal of Cardiology. 1994;73(7):460–468. doi: 10.1016/0002-9149(94)90676-9. pmid:8141087
- 33. Yu CY, Lin CH, Yang YH. Human body surface area database and estimation formula. Burns. 2010;36(5):616–629. doi: 10.1016/j.burns.2009.05.013. pmid:19900761
- 34. Treleaven P, Wells J. 3D body scanning and healthcare applications. Computer. 2007;40(7):28–34. doi: 10.1109/MC.2007.225.
- 35.
Tahrani A, Boelaert K, Barnes R, Palin S, Field A, Redmayne H, et al. Body volume index: Time to replace body mass index? 2008;.
- 36. Wells JC, Treleaven P, Cole TJ. BMI compared with 3-dimensional body shape: the UK National Sizing Survey. The American Journal of Clinical Nutrition. 2007;85(2):419–425. pmid:17284738
- 37.
Romero-Corral A, Somers V, Lopez-Jimenez F, Korenfeld Y, Palin S, Boclaert K, et al. 3-D Body Scanners, Body Volume Index: A Novel, Reproducible and Automated Anthropometric Tool Associated with Cardiometabolic Biomarkers. In: Obesity. vol. 16. Obesity. vol. 16. Nature Publishing Group 75 Varick st, 9th flr, New York, NY 10013-1917 USA; 2008. p. S124–S124.
- 38. He S, Chen X. Could the new body shape index predict the new onset of diabetes mellitus in the Chinese population? PloS One. 2013;8(1):e50573. doi: 10.1371/journal.pone.0050573. pmid:23382801
- 39. Zhang ZQ, Deng J, He LP, Ling WH, Su YX, Chen YM. Comparison of various anthropometric and body fat indices in identifying cardiometabolic disturbances in chinese men and women. PloS one. 2013;8(8):e70893. doi: 10.1371/journal.pone.0070893. pmid:23951031
- 40.
NHANES (2002) National Health and Nutrition Examination Survey Anthropometry Procedures Manual. Technical report, National Center for Health Statistics @ONLINE; 2002. Available from: http://www.cdc.gov/nchs/data/nhanes/.
- 41.
NCHS (2006) Analytic and reporting guidelines: The National Health and Nutrition Examination Survey (NHANES). Technical report, national center for health statistics, centers for disease control and prevention, hyattsville, Maryland. @ONLINE; 2006. Available from: http://www.cdc.gov/nchs/data/nhanes/nhanes_03_04/nhanes_analytic_guidelines_dec_2005.pdf.
- 42.
NCHS (2011) National Health and Nutrition Examination Survey Data. @ONLINE; 2011. Available from: http://www.cdc.gov/nchs/nhanes/nhanes_questionnaires.htm.
- 43.
Robinette KM, Daanen H, Paquet E. The CAESAR project: a 3-D surface anthropometry survey. In: 3-D Digital Imaging and Modeling, 1999. Proceedings. Second International Conference on. IEEE; 1999. p. 380–386.
- 44.
Cyberware scanner @ONLINE;. Available from: http://cyberware.com/products/scanners/.
- 45.
Adjeroh D, Cao D, Piccirilli M, Ross A. Predictability and correlation in human metrology. In: Information Forensics and Security (WIFS), 2010 IEEE International Workshop on. IEEE; 2010. p. 1–6.
- 46.
Cao D, Chen C, Adjeroh D, Ross A. Predicting gender and weight from human metrology using a copula model. In: Biometrics: Theory, Applications and Systems (BTAS), 2012 IEEE Fifth International Conference on. IEEE; 2012. p. 162–169.
- 47. Shuter B, Aslani A. Body surface area: Du bois and Du bois revisited. European Journal of Applied Physiology. 2000;82(3):250–254. doi: 10.1007/s004210050679. pmid:10929220
- 48. Ashwell M, Cole TJ, Dixon AK. Obesity: new insight into the anthropometric classification of fat distribution shown by computed tomography. BMJ. 1985;290(6483):1692–1694. doi: 10.1136/bmj.290.6483.1692. pmid:3924217
- 49. Petursson H, Sigurdsson JA, Bengtsson C, Nilsen TI, Getz L. Body configuration as a predictor of mortality: comparison of five anthropometric measures in a 12 year follow-up of the Norwegian HUNT 2 study. PloS One. 2011;6(10):e26621. doi: 10.1371/journal.pone.0026621. pmid:22028926
- 50. Daniell N, Olds T, Tomkinson G. Technical note: Criterion validity of whole body surface area equations: A comparison using 3D laser scanning. American Journal of Physical Anthropology. 2012;148(1):148–155. doi: 10.1002/ajpa.22051. pmid:22460277
- 51. Kom EL, Graubard BI, Midthune D. Time-to-event analysis of longitudinal follow-up of a survey: choice of the time-scale. American Journal of Epidemiology. 1997;145(1):72–80. doi: 10.1093/oxfordjournals.aje.a009034.
- 52.
Cox DR, Oakes D. Analysis of survival data. vol. 21. CRC Press; 1984.
- 53. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. Journal of the American statistical association. 1958;53(282):457–481. doi: 10.1080/01621459.1958.10501452.
- 54. Hsieh S, Yoshinaga H, Muto T. Waist-to-height ratio, a simple and practical index for assessing central fat distribution and metabolic risk in Japanese men and women. International journal of obesity. 2003;27(5):610–616. doi: 10.1038/sj.ijo.0802259. pmid:12704405
- 55. Browning LM, Hsieh SD, Ashwell M. A systematic review of waist-to-height ratio as a screening tool for the prediction of cardiovascular disease and diabetes: 0· 5 could be a suitable global boundary value. Nutrition Research Reviews. 2010;23(02):247–269. doi: 10.1017/S0954422410000144. pmid:20819243
- 56. Ashwell M, Gunn P, Gibson S. Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: systematic review and meta-analysis. Obesity Reviews. 2012;13(3):275–286. doi: 10.1111/j.1467-789X.2011.00952.x. pmid:22106927
- 57. Li WC, Chen IC, Chang YC, Loke SS, Wang SH, Hsiao KY. Waist-to-height ratio, waist circumference, and body mass index as indices of cardiometabolic risk among 36,642 Taiwanese adults. European Journal of Nutrition. 2013;52(1):57–65. doi: 10.1007/s00394-011-0286-0. pmid:22160169
- 58. McGee DL, Collaboration DP, et al. Body mass index and mortality: a meta-analysis based on person-level data from twenty-six observational studies. Annals of Epidemiology. 2005;15(2):87–97. doi: 10.1016/j.annepidem.2004.05.012. pmid:15652713
- 59. Janssen I, Mark AE. Elevated body mass index and mortality risk in the elderly. Obesity Reviews. 2007;8(1):41–59. doi: 10.1111/j.1467-789X.2006.00248.x. pmid:17212795
- 60. Carnethon MR, De Chavez PJD, Biggs ML, Lewis CE, Pankow JS, Bertoni AG, et al. Association of weight status with mortality in adults with incident diabetes. JAMA. 2012;308(6):581–590. doi: 10.1001/jama.2012.9282. pmid:22871870
- 61. Lainscak M, von Haehling S, Doehner W, Anker SD. The obesity paradox in chronic disease: facts and numbers. Journal of Cachexia, Sarcopenia and Muscle. 2012;3(1):1–4. doi: 10.1007/s13539-012-0059-5. pmid:22450395
- 62. Doehner W, Clark A, Anker SD. The obesity paradox: weighing the benefit. European Heart Journal. 2009;p. ehp339. doi: 10.1093/eurheartj/ehp339
- 63. Padwal RS, Pajewski NM, Allison DB, Sharma AM. Using the Edmonton obesity staging system to predict mortality in a population-representative cohort of people with overweight and obesity. Canadian Medical Association Journal. 2011;183(14):E1059–E1066. doi: 10.1503/cmaj.110387. pmid:21844111